![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/09 | |
C07K 7/06 | |||
A61K 39/00 |
(11) | Number of the document | 2553096 |
(13) | Kind of document | T |
(96) | European patent application number | 11762265.4 |
Date of filing the European patent application | 2011-03-30 | |
(97) | Date of publication of the European application | 2013-02-06 |
(45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2011/001909 |
Date | 2011-03-30 |
(87) | Number | WO 2011/122022 |
Date | 2011-10-06 |
(30) | Number | Date | Country code |
320577 P | 2010-04-02 | US |
(72) |
NAKAMURA, Yusuke, JP
TSUNODA, Takuya, JP
OHSAWA, Ryuji, JP
YOSHIMURA, Sachiko, JP
WATANABE, Tomohisa, JP
|
(73) |
Oncotherapy Science, Inc.,
2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012,
JP
|
(54) | ECT2 PEPTIDES AND VACCINES INCLUDING THE SAME |
ECT2 PEPTIDES AND VACCINES INCLUDING THE SAME |